PRINCETON, NJ -- July 12, 2010 -- GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders. The safety and efficacy of Optison with exercise stress or pharmacologic stress testing have not been established.
Innovative ultrasound device takes inaugural "Breakthrough Technology Award"
WAUWATOSA, WI, June 18, 2010 -- GE Healthcare (NYSE: GE) is pleased to announce that its innovative, pocket-sized, ultrasound device called the Vscan was named the winner in the Breakthrough Technology Award category of the American Technology Awards. The awards are organized by the foundation of TechAmerica, a technology industry trade association. The announcement was made Wednesday at the foundation's Eighth Annual Technology and Government dinner in Washington, D.C.
business unit
tags
Centricity Advance Utilizes Software as a Service (Saas) Technology to Provide Small Practices with an EMR that is Easy to Install, Use and Maintain
WASHINGTON, D.C. -- JUNE 15, 2010 -- At a press unveiling this afternoon, GE Healthcare will demonstrate the newest addition to the Centricity® family of healthcare IT solutions, Centricity Advance.
business unit
tags
- Iobenguane I 123 Injection Studied for Its Ability to Identify Risk in Patients with Symptomatic Heart Failure (HF)
PRINCETON, NJ, May 17, 2010 --The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) trial, the results of which were published in the May 18th, 2010 issue of the Journal of the American College of Cardiology, is a prospective study evaluating cardiac sympathetic nerve imaging using Iobenguane I 123 Injection (AdreView™) for identifying symptomatic heart failure patients most likely t
business unit
tags
GE showcases ultrasound innovations and healthymagination at AIUM 2010 convention
SAN DIEGO, CA, MARCH 24, 2010 ― GE Healthcare (NYSE: GE) today announced that an important new feature has been added to its LOGIQ E9 platform; elastography. The enhanced device is on display at the American Institute of Ultrasound in Medicine's (AIUM) 2010 Annual Convention in San Diego (booth 301).
business unit
tags
InConcertCare community health center network uses $2 million in federal grant money to partner with GE Centricity EMR.
BARRINGTON, Ill. -- MARCH 8, 2010 -- GE Healthcare, a leading provider of healthcare information technology (HIT), today announced the selection of its HIT solution for community health centers by InConcertCare, a health center-controlled network of eight community and migrant health centers that provides care to 78,000 people in underserved communities throughout Iowa and Nebraska.